EXEL Competitors & Alternatives
Compare Exelixis Inc with similar stocks in the same industry
Biotechnology
EXEL
Main Stock$69.96
Tradestie Score
27
Market Cap
$11.09B
P/E Ratio
21.1
Revenue Growth
0.1%
Analyst Upside
-12.0%
Top Competitors
216 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
GMAB
Genmab A/S ADS
|
$52.10
|
$19.56B | 46.2 | 33 | Compare |
|
INCY
Incyte Genomics Inc
|
$122.22
|
$16.93B | 61.4 | 50 | Compare |
|
RPRX
Royalty Pharma plc Class A Ordinary Shares
|
$69.24
|
$15.70B | 45.4 | 40 | Compare |
|
SMMT
Summit Therapeutics Inc. Common Stock
|
$15.40
|
$15.22B | - | 48 | Compare |
|
NBIX
Neurocrine Biosciences Inc
|
$170.88
|
$13.59B | 25.1 | 23 | Compare |
|
ASND
Ascendis Pharma A/S American Depositary Shares
|
$265.47
|
$12.36B | 19.7 | 36 | Compare |
|
ROIV
Roivant Sciences Ltd. Common Shares
|
$40.41
|
$10.76B | - | 31 | Compare |
|
MRNA
Moderna, Inc. Common Stock
|
$233.68
|
$10.74B | - | 39 | Compare |
|
BMRN
BioMarin Pharmaceuticals Inc
|
$56.75
|
$10.53B | - | 53 | Compare |
|
IONS
Ionis Pharmaceuticals, Inc. Common Stock
|
$27.46
|
$10.49B | - | 45 | Compare |
More EXEL Analysis
Data updated: Nov 12, 2026 | Industry: Biotechnology (SIC 2836)
216 stocks in this industry